Announcements Trials
Browse Landscape

Phase

Phase 4 3Phase NA 2Phase 1 1

Status

Unknown 3Completed 2

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2Genitourinary 1

Conditions

Pain 2Carcinoma, Hepatocellular 2Prostatic Neoplasms 1

Interventions

Metformin 16Cyclophosphamide 16Drug Therapy 14Dexamethasone 14Cisplatin 13Cytarabine 11Gemcitabine 10Radiotherapy 9Oxaliplatin 9Carboplatin 9Vincristine 8Paclitaxel 8Idarubicin 8Etoposide 8Docetaxel 8ulipristal acetate 7icotinib 7Sodium Chloride 7Methotrexate 7Fluorouracil 7Dexmedetomidine 7entecavir 6Thalidomide 6Surgical Procedures, Operative 6Sorafenib 6Pemetrexed 6Leuprolide 6Granulocyte Colony-Stimulating Factor 6Epirubicin 6Doxorubicin 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Unknown × Sufentanil × Clear all
NCT05957653 2023-07-24

Lidocaine Combined With Sufentanil for Preventing Catheter-related Bladder Discomfort

RenJi Hospital

Phase 4 Unknown
140 enrolled
Genitourinary

Prostatic Neoplasms

NCT05670561 2023-03-29

Effects of Esketamine on Acute Abdominal Pain After TACE in Patients With Hepatocellular Carcinoma

The Second Affiliated Hospital of Chongqing Medical University

Phase 4 Unknown
60 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Pain

NCT05416073 2023-02-24

TACE-HAIC

The Second Affiliated Hospital of Chongqing Medical University

Phase 4 Unknown
70 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡